321 related articles for article (PubMed ID: 28222778)
1. Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study.
Chappell FM; Del Carmen Valdés Hernández M; Makin SD; Shuler K; Sakka E; Dennis MS; Armitage PA; Muñoz Maniega S; Wardlaw JM
Trials; 2017 Feb; 18(1):78. PubMed ID: 28222778
[TBL] [Abstract][Full Text] [Related]
2. White Matter Hyperintensity-Associated Blood-Brain Barrier Disruption and Vascular Risk Factors.
Gupta N; Simpkins AN; Hitomi E; Dias C; Leigh R;
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):466-471. PubMed ID: 29100854
[TBL] [Abstract][Full Text] [Related]
3. White matter hyperintensities and recurrent stroke risk in patients with stroke with small-vessel disease.
Park JH; Heo SH; Lee MH; Kwon HS; Kwon SU; Lee JS;
Eur J Neurol; 2019 Jun; 26(6):911-918. PubMed ID: 30637882
[TBL] [Abstract][Full Text] [Related]
4. Correlation between Fibrinogen and White Matter Hyperintensities among Nondiabetic Individuals with Noncardiogenic Ischemic Stroke.
You CJ; Liu D; Liu LL; Liu QQ; Li GZ
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2360-2366. PubMed ID: 29773351
[TBL] [Abstract][Full Text] [Related]
5. Computational quantification of brain perivascular space morphologies: Associations with vascular risk factors and white matter hyperintensities. A study in the Lothian Birth Cohort 1936.
Ballerini L; Booth T; Valdés Hernández MDC; Wiseman S; Lovreglio R; Muñoz Maniega S; Morris Z; Pattie A; Corley J; Gow A; Bastin ME; Deary IJ; Wardlaw J
Neuroimage Clin; 2020; 25():102120. PubMed ID: 31887717
[TBL] [Abstract][Full Text] [Related]
6. White Matter Hyperintensity, Immediate Antihypertensive Treatment, and Functional Outcome After Acute Ischemic Stroke.
Zhu S; Qian S; Xu T; Peng H; Dong R; Wang D; Yuan X; Guo L; Zhang Y; Geng D; Zhong C
Stroke; 2020 May; 51(5):1608-1612. PubMed ID: 32233741
[TBL] [Abstract][Full Text] [Related]
7. White Matter Hyperintensity-Adjusted Critical Infarct Thresholds to Predict a Favorable 90-Day Outcome.
Patti J; Helenius J; Puri AS; Henninger N
Stroke; 2016 Oct; 47(10):2526-33. PubMed ID: 27633020
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensity reduction and outcomes after minor stroke.
Wardlaw JM; Chappell FM; Valdés Hernández MDC; Makin SDJ; Staals J; Shuler K; Thrippleton MJ; Armitage PA; Muñoz-Maniega S; Heye AK; Sakka E; Dennis MS
Neurology; 2017 Sep; 89(10):1003-1010. PubMed ID: 28794252
[TBL] [Abstract][Full Text] [Related]
9. Long-term progression of white matter hyperintensities in ischemic stroke.
Holmegaard L; Jensen C; Redfors P; Blomstrand C; Jern C; Jood K
Acta Neurol Scand; 2018 Dec; 138(6):548-556. PubMed ID: 30152523
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between White Matter Hyperintensities Penumbra and Cavity Formation.
Zhang X; Ding L; Yang L; Qin W; Li Y; Li S; Hu W
Med Sci Monit; 2016 Jan; 22():41-9. PubMed ID: 26729408
[TBL] [Abstract][Full Text] [Related]
11. Differential impact of white matter hyperintensities on long-term outcomes in ischemic stroke patients with large artery atherosclerosis.
Baik M; Kim K; Yoo J; Kim HC; Jeong SH; Kim KH; Park HJ; Kim YD; Heo JH; Nam HS
PLoS One; 2017; 12(12):e0189611. PubMed ID: 29232701
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal white matter hyperintensity changes and cognitive decline in patients with minor stroke.
Jiang J; Yao K; Huang X; Zhang Y; Shen F; Weng S
Aging Clin Exp Res; 2022 May; 34(5):1047-1054. PubMed ID: 35084664
[TBL] [Abstract][Full Text] [Related]
13. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities.
Tosto G; Zimmerman ME; Carmichael OT; Brickman AM;
JAMA Neurol; 2014 Jul; 71(7):872-7. PubMed ID: 24821476
[TBL] [Abstract][Full Text] [Related]
14. Association of White Matter Hyperintensities With Short-Term Outcomes in Patients With Minor Cerebrovascular Events.
Zerna C; Yu AYX; Modi J; Patel SK; Coulter JI; Smith EE; Coutts SB
Stroke; 2018 Apr; 49(4):919-923. PubMed ID: 29540612
[TBL] [Abstract][Full Text] [Related]
15. Do Lacunar Infarcts Have Different Aetiologies? Risk Factor Profiles of Lacunar Infarcts in Deep White Matter and Basal Ganglia: The Second Manifestations of ARTerial Disease-Magnetic Resonance Study.
Kloppenborg RP; Nederkoorn PJ; Grool AM; De Cocker LJ; Mali WP; van der Graaf Y; Geerlings MI;
Cerebrovasc Dis; 2017; 43(3-4):161-168. PubMed ID: 28142144
[TBL] [Abstract][Full Text] [Related]
16. Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.
Scharf EL; Graff-Radford J; Przybelski SA; Lesnick TG; Mielke MM; Knopman DS; Preboske GM; Schwarz CG; Senjem ML; Gunter JL; Machulda M; Kantarci K; Petersen RC; Jack CR; Vemuri P
Stroke; 2019 Nov; 50(11):3037-3044. PubMed ID: 31510903
[TBL] [Abstract][Full Text] [Related]
17. Volumetric White Matter Hyperintensity Ranges Correspond to Fazekas Scores on Brain MRI.
Andere A; Jindal G; Molino J; Collins S; Merck D; Burton T; Stretz C; Yaghi S; Sacchetti DC; Jamal SE; Reznik ME; Furie K; Cutting S
J Stroke Cerebrovasc Dis; 2022 Apr; 31(4):106333. PubMed ID: 35158149
[TBL] [Abstract][Full Text] [Related]
18. White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction.
Andersen SD; Larsen TB; Gorst-Rasmussen A; Yavarian Y; Lip GY; Bach FW
Cerebrovasc Dis; 2017; 43(1-2):17-24. PubMed ID: 27750251
[TBL] [Abstract][Full Text] [Related]
19. Cerebral white matter hyperintensities indicate severity and progression of coronary artery calcification.
Kneihsl M; Gattringer T; Hofer E; Rainer PP; Ranner G; Fandler-Höfler S; Haidegger M; Perl S; Enzinger C; Schmidt R
Sci Rep; 2024 Feb; 14(1):4664. PubMed ID: 38409473
[TBL] [Abstract][Full Text] [Related]
20. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease.
Wang Y; Yang Y; Wang T; Nie S; Yin H; Liu J
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105275. PubMed ID: 32992182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
